Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection

Brain, Behavior, & Immunity - Health · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles